AVALON INVESTMENT & ADVISORY – SPDR S&P Biotech ETF Transaction History
AVALON INVESTMENT & ADVISORY portfolio value:
$1.76M
portfolio value
AVALON INVESTMENT & ADVISORY quarter portfolio value change:
+6.80%
quarter
SPDR S&P Biotech ETF 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.90% | -1.39K shares | 8K | $79.32 | 22.21K |
| Q2 2022 | share | Decrease | -3.61% | -885 shares | -448K | $74.27 | 23.61K |
| Q1 2022 | share | Increase | +12.72% | 2.76K shares | -231K | $89.88 | 24.49K |
| Q4 2021 | share | Decrease | -14.29% | -3.62K shares | -754K | $113.24 | 21.73K |
| Q3 2021 | share | Increase | +2.69% | 664 shares | -156K | $125.71 | 25.35K |
| Q2 2021 | share | Increase | +9.55% | 2.15K shares | 286K | $135.4 | 24.68K |
| Q1 2021 | share | Increase | +4.13% | 893 shares | 10K | $135.65 | 22.53K |
| Q4 2020 | share | Decrease | -2.62% | -582 shares | 570K | $140.74 | 21.64K |
| Q3 2020 | share | Decrease | -11.91% | -3.00K shares | -347K | $111.27 | 22.22K |
| Q2 2020 | share | Decrease | -22.48% | -7.31K shares | 304K | $111.7 | 25.22K |
| Q1 2020 | share | Decrease | -5.05% | -1.73K shares | -740K | $77.26 | 32.54K |
| Q4 2019 | share | Decrease | -0.56% | -194 shares | 632K | $94.88 | 34.27K |
| Q3 2019 | share | Decrease | -1.26% | -440 shares | -434K | $76.07 | 34.47K |
| Q2 2019 | share | Increase | 0.00% | 34.91K shares | 3.06M | $87.5 | 34.91K |
| Q1 2019 | share | Increase | +0.72% | 248 shares | 668K | $90.32 | 34.59K |
| Q4 2018 | share | Increase | +5.42% | 1.76K shares | -660K | $71.58 | 34.34K |
| Q3 2018 | share | Increase | +7.50% | 2.27K shares | 239K | $95.62 | 32.58K |
| Q2 2018 | share | Decrease | -18.71% | -6.97K shares | -387K | $94.87 | 30.31K |
| Q1 2018 | share | Increase | +10.45% | 3.52K shares | 407K | $87.38 | 37.28K |
| Q4 2017 | share | Increase | +3.46% | 1.12K shares | 40K | $84.48 | 33.76K |
| Q3 2017 | share | Decrease | -0.75% | -247 shares | 287K | $86.14 | 32.63K |
| Q2 2017 | share | Increase | +1.32% | 427 shares | 288K | $76.76 | 32.87K |
| Q1 2017 | share | Increase | +10.78% | 3.15K shares | 516K | $68.86 | 32.45K |
| Q4 2016 | share | Increase | +0.37% | 108 shares | -201K | $58.76 | 29.29K |
| Q3 2016 | share | Increase | 0.00% | 29.18K shares | 1.93M | $65.79 | 29.18K |